In United States market
Dr Reddy's Laboratories announced that it has launched Lamotrigine Orally Disintegrating Tablets in 25 mg, 50 mg, 100 mg and 200 mg, a therapeutic equivalent of generic version of Lamictal ODT (lamotrigine) Orally Disintegrating Tablets in the United States market approved by the USFDA.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content